80
45
Growth Score 80 in past quarter
-6 pts
Heat Score 45 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1102226
ASCIL Biopharm is a drug-delivery company developing proprietary miniaturized injectable and locally acting therapeutics.
About the Company
ASCIL Biopharm is a drug-delivery company developing proprietary miniaturized injectable and locally acting therapeutics to enhance the safety, effectiveness, and convenience of administration of drugs for chronic high burden diseases. The company's mission is to create pharmaceutical products and therapeutic treatments of improved efficacy,
comfort, and compliance through its new patented DDS technology platforms.
